Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cloudbreak Pharma
Irvine, California, United Statescloudbreakpharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Cloudbreak Pharma is a clinical-stage ophthalmic biotechnology company developing topical drugs for chronic eye diseases with few treatment options. Its lead candidate, CBT‑001, is in Phase 3 trials for pterygium. The company’s pipeline also includes programs in meibomian gland dysfunction and pinguecula at earlier stages[6][5][2].
- Therapeutic areas
- Ophthalmology
- Modalities
- Small moleculeAntibody-drug conjugate (ADC)Chemical drug (as a general category)
- Industry
- Biotech
02
Partnerships
Santen Pharmaceutical Co., Ltd. — licensing agreement August 2024 for development/commercialization of CBT‑001 in Japan, South Korea, Vietnam, Thailand, Malaysia, Philippines, Singapore, Indonesia[2].Grand Pharma — exclusive commercialization license April 2020 for mainland China/Hong Kong/Macau/Taiwan region[2].
Beyond the preview
Go deeper on Cloudbreak Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cloudbreak Pharma.